GLAXOSMITHKLINE

GlaxoSmithKline is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. The company aims to bring differentiated, high-quality and needed healthcare products to as many people as possible, with its 3 global businesses, scientific and technical know-how, and talented people. GSK's Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in respiratory and HIV. Our R&D approach ... focuses on science related to the immune system, the use of genetics, and advanced technologies. The Vaccines business has a broad portfolio and innovative pipeline of vaccines to help protect people throughout life. It delivers over two million vaccine doses per day to people living in over 160 countries. The Consumer Healthcare business develops and markets an innovative portfolio of consumer preferred and expert-recommended brands in the Pain relief, Respiratory, Digestive health, Oral Health, Nutrition, and Skin health categories.
GLAXOSMITHKLINE
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1929-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.gsk.com
Total Employee:
10001+
Status:
Active
Contact:
2157517173
Total Funding:
25.51 M USD
Technology used in webpage:
Google Font API LetsEncrypt Font Awesome Domain Not Resolving Mobile Non Scaleable Content Nginx Euro Organization Schema IPv6 JsDelivr
Similar Organizations
Bayer
Bayer is a life science company that specializes in the areas of health care and agriculture.
GSK - Cephalosporins Antibiotics Business
GlaxoSmithKline's Cephalosporins based brands composed of Zinnat, Zinacef and Fortum
Jaber Ibn Hayyan Pharmaceutical
Jaber Ibn Hayyan Pharmaceutical manufactures drugs like anti-biotic, non-antibiotic , topical, oral and others.
Selvita
Selvita is a drug discovery company engaged in the research and development of breakthrough therapies in the area of oncology.
Current Advisors List
Board_member
Board_member
2015-05-07
Advisor
Board_member
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Emma Walmsley CEO @ GlaxoSmithKline
CEO
Iain Mackay Chief Financial Officer @ GlaxoSmithKline
Chief Financial Officer
Brian McNamara CEO GSK Consumer Healthcare @ GlaxoSmithKline
CEO GSK Consumer Healthcare
2016-01-01
Hal Barron President Research And Development @ GlaxoSmithKline
President Research And Development
2018-01-01
Roger Connor President, Global Vaccines @ GlaxoSmithKline
President, Global Vaccines
Olivier Le Bussy R&D Scientist @ GlaxoSmithKline
R&D Scientist
Pascal Ducheix Digital Media Procurement Director @ GlaxoSmithKline
Digital Media Procurement Director
Katrin Haram Sales and Marketing Coordinator @ GlaxoSmithKline
Sales and Marketing Coordinator
Mark G. Miller Team Member @ GlaxoSmithKline
Team Member
Love Oyeniran RPA Tech Security and Risk Consultant @ GlaxoSmithKline
RPA Tech Security and Risk Consultant
2018-09-01
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2022-05-31 | Affinivax | Affinivax acquired by GlaxoSmithKline | 2.1 B USD |
2022-04-13 | Sierra Oncology | Sierra Oncology acquired by GlaxoSmithKline | 1.9 B USD |
2019-09-12 | Sitari Pharmaceuticals | Sitari Pharmaceuticals acquired by GlaxoSmithKline | N/A |
2018-12-03 | TESARO | TESARO acquired by GlaxoSmithKline | 5.1 B USD |
2015-02-11 | GlycoVaxyn | GlycoVaxyn acquired by GlaxoSmithKline | 190 M USD |
2013-05-29 | Okairos | Okairos acquired by GlaxoSmithKline | 325 M USD |
2012-08-03 | Human Genome Sciences | Human Genome Sciences acquired by GlaxoSmithKline | 3 B USD |
2012-05-15 | CellZome | CellZome acquired by GlaxoSmithKline | 61 M GBP |
2010-12-13 | MaxiNutrition | MaxiNutrition acquired by GlaxoSmithKline | 162 M GBP |
2010-12-07 | Nanjing MeiRui Pharma Co., Ltd. | Nanjing MeiRui Pharma Co., Ltd. acquired by GlaxoSmithKline | 70 M USD |
Investors List
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-03-23 | LifeMine Therapeutics | GlaxoSmithKline investment in Series C - LifeMine Therapeutics | 175 M USD |
2020-12-18 | Adrestia Therapeutics | GlaxoSmithKline investment in Series A - Adrestia Therapeutics | 172 M GBP |
2020-07-20 | CureVac | GlaxoSmithKline investment in Corporate Round - CureVac | 130 M GBP |
2020-04-07 | Vir Biotechnology | GlaxoSmithKline investment in Post-IPO Equity - Vir Biotechnology | 250 M USD |
2019-09-18 | SetPoint Medical | GlaxoSmithKline investment in Venture Round - SetPoint Medical | 15.7 M USD |
2019-04-01 | SpringWorks Therapeutics | GlaxoSmithKline investment in Series B - SpringWorks Therapeutics | 125 M USD |
2018-07-24 | 23andMe | GlaxoSmithKline investment in Corporate Round - 23andMe | 300 M USD |
2016-02-02 | Spero Therapeutics | GlaxoSmithKline investment in Series B - Spero Therapeutics | 30 M USD |
2015-11-04 | Atreca | GlaxoSmithKline investment in Series A - Atreca | 56 M USD |
2015-06-23 | Gladius Pharmaceuticals | GlaxoSmithKline investment in Series A - Gladius Pharmaceuticals | 4.1 M CAD |
Newest Events participated





Key Employee Changes
Official Site Inspections
http://www.gsk.com Semrush global rank: 78.15 K Semrush visits lastest month: 1.37 M
- Host name: 221.83.117.34.bc.googleusercontent.com
- IP address: 34.117.83.221
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "GlaxoSmithKline"
Board of directors and leadership team - GSK
Trade marks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG > Modern Slavery Act statement …See details»
Company | GSK
Trade marks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. Registered office: 79 New Oxford Street, London. United …See details»
Company | GSK Canada
Trademarks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. GlaxoSmithKline Inc. 100 Milverton Drive, Suite 800, …See details»
GSK - The Org
GSK. 297 followers ‌ GlaxoSmithKline is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. ...See details»
GSK plc - Wikipedia
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and …See details»
Purpose, strategy and culture | GSK Canada
This means more GSK vaccines and medicines, including innovative new products, will reach more people who need them than ever before. Our performance. Vaccines delivered in 2021 >767mn. Medicine doses delivered …See details»
Governance - GSK
Ahead Together oversight. Our Board focuses on priorities agreed for the year to support delivery of GSK’s corporate strategy encapsulated in our Ahead Together ambitions. Our Board and management agendas are completely aligned with …See details»
Home | GSK US
The homepage of the GSK USA website. March 12 2025 ViiV Healthcare announces new implementation study data showing zero cases of HIV with Apretude, the only long-acting injectable approved for HIV PrEP ; March 12 …See details»
GSK - Crunchbase Company Profile & Funding
GSK manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company is headquartered in Brentford, Hounslow, United Kingdom. Lists Featuring This Company. Edit Lists Featuring This …See details»
Org Chart GSK - The Official Board
The organizational chart of GSK displays its 197 main executives including Emma Walmsley, Julie Brown, Luke Miels and Adam Walker. Toggle navigation The Official Board. Search. Search. Search by segment. Sign In. Business E-mail* …See details»
Purpose, strategy and culture | GSK US
GSK is a company where outstanding people can thrive. We prioritize innovation in vaccines and specialty medicines, maximizing the increasing opportunities to prevent and treat disease. At …See details»
Company | GSK US
Getting ahead of disease is one of the greatest, most inspiring challenges there is on the planet. By pursuing this purpose together, we have the scale and expertise to positively impact the …See details»
GSK - Leadership Team - The Org
The Leadership Team at GSK is responsible for setting the strategic direction and operational oversight of the company. Comprising senior executives from various functions, including …See details»
Purpose, strategy and culture - GSK
Culture at GSK is something we all own. It powers our purpose, drives delivery of our strategy and helps make GSK a place where people can thrive. Our culture of being ambitious for patients, …See details»
Gsk organizational presentaion | PPT - SlideShare
May 21, 2015 GSK aims to grow a diversified global business, deliver more innovative products, and simplify its operating model as it is a large, complex organization with over 96,000 …See details»
GSK Company Profile - Office Locations, Competitors, Revenue
Oct 29, 2024 GSK has 5 employees across 149 locations and £31.38 b in annual revenue in FY 2024. See insights on GSK including office locations, competitors, revenue, financials, …See details»
GSK's Omjjara (momelotinib) approved in Singapore as the first ...
14 hours ago GSK Singapore today announced that Omjjara (momelotinib) has been locally approved for treatment of disease-related splenomegaly or symptoms in adult patients with …See details»
Home | GSK
Trade marks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. Registered office: 79 New Oxford Street, London. United …See details»
Inclusion | GSK US
At GSK, we foster an inclusive environment that embraces and celebrates different perspectives and experiences, allowing everyone to be themselves so we can all perform at our best for …See details»
GSK and the WWF team up to bolster pharmaceutical sustainability
17 hours ago WWF and GSK have teamed up to protect and restore freshwater ecosystems across the Asian continent. The five year, multi-million pound partnership will help GSK to …See details»